Earnings Call · Q3 FY2024·2024-11-13

Q3 24EPS +48.74%·Rev n/aQ2 24EPS -100.00%*·Rev n/aQ1 24EPS +54.90%·Rev n/aQ4 23EPS +10.00%·Rev n/a⚠ consensus missing

BioCardia, Inc. BCDA

Miranda Peto — Investor Relations or Communications

Peter Altman — President and Chief Executive Officer

David McClung — Chief Financial Officer

−2.1%1d on move date−2.1% vs SPY3d−22.9%5d−15.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BCDA calls or request research access.

More BCDA calls Browse calls Request research access